Alan Whone

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

Alan Whone, Ray L. Watts, A. Jon Stoessl et al. · Annals of Neurology · 2003 · 828 citations

Medicine, Neurology, Pharmacology +17

Parkinson's disease–associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

Wenzhang Wang, Xinglong Wang, Hisashi Fujioka et al. · Nature Medicine · 2015 · 330 citations

Life Sciences, Molecular Biology, Neuroscience +12

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial

Emily J. Henderson, Stephen R. Lord, Matthew A. Brodie et al. · The Lancet Neurology · 2016 · 307 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease

Alan Whone, Matthias Luz, M Boca et al. · Brain · 2019 · 283 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation

Ian J. McGough, Florian Steinberg, Da Jia et al. · Current Biology · 2014 · 217 citations · Full text

Life Sciences, Genetics, Molecular Biology +17